,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,377,1,3,,10321213,1794427,Inactive,42741659.0,5243.0,,,MDR-1,Other,,
1,608,1,6,,11537477,1794427,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
2,940,1,2,,26613128,1794427,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
3,1033,2,2,,11537477,1794427,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
4,1332,1,1,,49698484,1794427,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
5,1422,1,1,,26613128,1794427,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
6,1549,1,2,,11537477,1794427,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
7,1552,1,3,,11537477,1794427,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
8,1637,1,2,,11537477,1794427,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
9,1648,1,2,,11537477,1794427,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
10,1850,2,1,,56463713,1794427,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
11,1863,2,1,,56463713,1794427,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
12,1899,1,3,,56463713,1794427,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
13,1903,2,3,,56463713,1794427,Active,297591903.0,29031019.0,14.67,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
14,1906,1,3,,56463713,1794427,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
15,1947,1,2,,56463713,1794427,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
16,1950,1,3,,56463713,1794427,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
17,1962,1,2,,56463713,1794427,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
18,1974,1,2,,56463713,1794427,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
19,1987,1,2,,56463713,1794427,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
20,2016,1,3,,56463713,1794427,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
21,2023,1,3,,56463713,1794427,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
22,2025,1,3,,56463713,1794427,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
23,2029,1,3,,56463713,1794427,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
24,2052,2,1,,56463713,1794427,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
25,2057,1,2,,56463713,1794427,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
26,2066,1,4,,56463713,1794427,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
27,2101,1,1,,56463713,1794427,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
28,2102,1,2,,56463713,1794427,Inactive,297591903.0,29031019.0,,EC50,Identification of SV40 T antigen inhibitors: Cytotoxicity screen of selected hits,Confirmatory,,
29,2129,1,2,,56463713,1794427,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
30,2130,1,3,,56463713,1794427,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
31,2174,1,3,,56463713,1794427,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
32,2177,1,3,,56463713,1794427,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
33,2234,1,2,,56463713,1794427,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
34,2235,1,2,,56463713,1794427,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
35,2240,1,1,,85788779,1794427,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
36,2241,1,1,,85788779,1794427,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
37,2275,1,1,,85788779,1794427,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
38,2280,2,3,,56463713,1794427,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
39,2300,1,3,,56463713,1794427,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
40,2313,1,1,,85788779,1794427,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
41,2322,1,1,,85788779,1794427,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
42,2330,1,1,,85788779,1794427,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
43,2380,1,2,,56463713,1794427,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
44,2391,1,1,,56463713,1794427,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
45,2435,1,2,,56463713,1794427,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
46,2445,1,2,,56463713,1794427,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
47,2462,1,1,,56463713,1794427,Inconclusive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
48,2462,1,1,,56463713,1794427,Inconclusive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
49,2501,1,1,,56463713,1794427,Active,,,8.41,IC50,"A biochemical assay using the ADP-Hunter methodology, purified TAg, and ATP to identify compounds that inhibit the ATPase activity of Tag - Counter Screen",Confirmatory,,
50,2517,2,1,,56463713,1794427,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
51,2520,1,4,,56463713,1794427,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
52,2521,1,3,,56463713,1794427,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
53,2524,1,2,,56463713,1794427,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
54,2540,1,2,,56463713,1794427,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
55,2544,1,2,,56463713,1794427,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
56,2557,1,3,,56463713,1794427,Active,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
57,2599,1,2,,56463713,1794427,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
58,2606,1,2,,56463713,1794427,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
59,2629,1,1,,56463713,1794427,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
60,2650,2,1,,56463713,1794427,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
61,2661,1,1,,56463713,1794427,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
62,2676,1,2,,56463713,1794427,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
63,2685,1,1,,56463713,1794427,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
64,2690,1,2,,56463713,1794427,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
65,2716,1,1,,56463713,1794427,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
66,2717,1,2,,56463713,1794427,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
67,2718,1,1,,56463713,1794427,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
68,2751,2,2,,56463713,1794427,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
69,2796,1,4,,56463713,1794427,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
70,2797,1,2,,56463713,1794427,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
71,2805,2,2,,56463713,1794427,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
72,2806,2,2,,56463713,1794427,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
73,2813,1,2,,56463713,1794427,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from Cherry Picked Plates,Screening,,
74,2825,1,2,,56463713,1794427,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
75,75271,6,3,,103207024,1794427,Unspecified,,,230.0,IC50,Inhibition glucose-6-phosphate hydrolysis in highly intact microsomal preparations obtained from livers of 20-h fasted rats.,Confirmatory,9003513.0,
76,91425,9,5,,103207024,1794427,Unspecified,82312013.0,,87.8,IC50,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",Confirmatory,10841789.0,
77,91426,9,5,,103207024,1794427,Active,82312013.0,,45.8,IC50,"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer",Confirmatory,10841789.0,
78,91561,3,9,,103207024,1794427,Unspecified,82312013.0,,,,Percentage inhibition of compound against 3'-processing of HIV-1 integrase at 100 ug/mL,Other,9083483.0,
79,91562,3,9,,103207024,1794427,Unspecified,82312013.0,,,,Percentage inhibition against strand transfer of HIV-1 integrase at 100 ug/mL,Other,9083483.0,
80,91578,4,9,,103207024,1794427,Unspecified,82312013.0,,,,Inhibition of Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration reaction at a concentration of 25 uM,Other,9986720.0,
81,93700,9,5,,103207024,1794427,Unspecified,82312013.0,,87.8,IC50,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 1,Confirmatory,9083483.0,
82,93702,9,5,,103207024,1794427,Unspecified,82312013.0,,58.2,IC50,Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 2,Confirmatory,9083483.0,
83,93705,9,5,,103207024,1794427,Active,82312013.0,,45.8,IC50,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 1,Confirmatory,9083483.0,
84,93707,9,5,,103207024,1794427,Active,82312013.0,,31.3,IC50,Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 2,Confirmatory,9083483.0,
85,104233,7,1,,103207024,1794427,Unspecified,,,,,Lethal dose (LD5) concentration inhibiting growth of MT-2 cells by 5%,Other,9986720.0,
86,106907,8,1,,103207024,1794427,Unspecified,,,497.0,ED50,Concentration that inhibits Human Immunodeficiency Virus Type 1 (HIV-1)-induced death of MT-2 cells,Confirmatory,9986720.0,
87,289011,7,3,,103207024,1794427,Unspecified,,,67920.0,IC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,17542634.0,
88,294174,3,10,,103207024,1794427,Unspecified,6686057.0,,,,Inhibition of diphenolase activity of mushroom tyrosinase at 0.049 mM,Other,17287127.0,
89,309262,6,2,,103207024,1794427,Unspecified,,,,,Antifungal activity against Candida albicans ATCC 90028 after 18 to 24 hrs,Other,17761420.0,
90,309265,6,2,,103207024,1794427,Unspecified,,,,,Antifungal activity against Candida krusei ATCC 6258,Other,17761420.0,
91,309266,3,3,,103207024,1794427,Unspecified,,,,,Lethality in brine shrimp at 100 ug/ml,Other,17761420.0,
92,311351,3,3,,103207024,1794427,Unspecified,,,,,Inhibition of Cu2+ induced human LDL oxidation,Other,17822297.0,
93,311973,3,3,,103207024,1794427,Active,,,,,Hepatoprotective activity against HBV in human HepG2.2.15 cells,Other,18029179.0,
94,311974,3,3,,103207024,1794427,Active,,,,,Antiviral activity against hepatitis B virus assessed as inhibition of viral particle production,Other,18029179.0,
95,336478,3,7,,103207024,1794427,Unspecified,,,,,Inhibition of COX2 at 100 uM by scintillation proximity assay,Other,12444669.0,
96,338030,3,7,,103207024,1794427,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic oxaloacetic transaminase release at 0.01 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
97,338031,3,7,,103207024,1794427,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic oxaloacetic transaminase release at 0.1 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
98,338032,3,7,,103207024,1794427,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic oxaloacetic transaminase release at 1 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
99,338033,3,7,,103207024,1794427,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic oxaloacetic transaminase release at 3 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
100,338034,3,7,,103207024,1794427,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic pyruvate transaminase release at 0.01 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
101,338035,3,7,,103207024,1794427,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic pyruvate transaminase release at 0.1 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
102,338036,3,7,,103207024,1794427,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamate pyruvate transaminase release at 1 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
103,338037,3,7,,103207024,1794427,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic pyruvate transaminase release at 3 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
104,355885,6,2,,103207024,1794427,Unspecified,,,,,Antimicrobial activity against Helicobacter pylori isolates after 36 hrs under aerobic condition by microdilution method,Other,12762812.0,
105,355887,6,2,,103207024,1794427,Inactive,,,,,Antimicrobial activity against Proteus mirabilis isolates after 36 hrs under aerobic condition by microdilution method,Other,12762812.0,
106,355888,3,3,,103207024,1794427,Inactive,,,,,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 36 hrs under aerobic condition by microdilution method,Other,12762812.0,
107,356132,6,3,,103207024,1794427,Active,,,39.5,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,12880319.0,
108,356133,6,2,,103207024,1794427,Unspecified,,,367.0,IC50,Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay,Confirmatory,12880319.0,
109,356134,6,2,,103207024,1794427,Unspecified,,,353.0,IC50,Cytotoxicity against human SW480 cells after 72 hrs by MTT assay,Confirmatory,12880319.0,
110,357272,6,4,,103207024,1794427,Unspecified,,,,IC50,Inhibition of A23187-induced LTB4 formation in human polymorphonuclear leukocytes,Confirmatory,2822857.0,
111,357273,6,4,,103207024,1794427,Unspecified,,,,IC50,"Inhibition of A23187-induced 12-hydroxy-5,8,10-heptadecatrienoic acid formation in human polymorphonuclear leukocytes",Confirmatory,2822857.0,
112,357274,6,4,,103207024,1794427,Unspecified,,,,IC50,Inhibition of A23187-induced 5HETE formation in human polymorphonuclear leukocytes,Confirmatory,2822857.0,
113,357275,6,4,,103207024,1794427,Unspecified,,,,IC50,Inhibition of A23187-induced 15HETE formation in human polymorphonuclear leukocytes,Confirmatory,2822857.0,
114,357283,3,4,,103207024,1794427,Unspecified,,,,,Enhancement of PGE2 formation in A-23187-stimulated human polymorphonuclear leukocytes at 100 uM,Other,2822857.0,
115,357288,3,4,,103207024,1794427,Unspecified,,,,,Cytotoxicity against human polymorphonuclear leukocytes assessed as occurrence of cell suspension or lactate dehydrogenase release at 1 to 1000 uM,Other,2822857.0,
116,378763,7,1,,103207024,1794427,Unspecified,,,,,Induction of resting HMNC proliferation assessed as [3H]thymidine uptake at 10 ug/mL after 3 days by lymphoproliferation test relative to control,Other,10096846.0,
117,378764,4,3,,103207024,1794427,Unspecified,,,,,Induction of phytohemagglutininin-activated HMNC proliferation assessed as [3H]thymidine uptake at 10 ug/mL after 3 days by lymphoproliferation test relative to control,Other,10096846.0,
118,378765,6,2,,103207024,1794427,Unspecified,,,,,Induction of phytohemagglutininin-activated HMNC proliferation assessed as [3H]thymidine uptake after 3 days by lymphoproliferation test,Other,10096846.0,
119,378766,6,2,,103207024,1794427,Unspecified,,,,,Induction of resting HMNC proliferation assessed as [3H]thymidine uptake after 3 days by lymphoproliferation test,Other,10096846.0,
120,378767,7,1,,103207024,1794427,Unspecified,,,,,Immunomodulatory activity in resting HMNC assessed as IFN-gamma production at 10 ug/mL after 3 days by EIA realtive to control,Other,10096846.0,
121,378768,3,4,,103207024,1794427,Active,,,,,Immunomodulatory activity in phytochemagglutininin-stimulatedHMNC assessed as IFN-gamma production at 10 ug/mL after 3 days by EIA realtive to control,Other,10096846.0,
122,378769,6,2,,103207024,1794427,Unspecified,,,,,Immunomodulatory activity in phytochemagglutininin-stimulatedHMNC assessed as IFN-gamma production after 3 days by EIA,Other,10096846.0,
123,378770,6,2,,103207024,1794427,Unspecified,,,,,Immunomodulatory activity in resting HMNC assessed as IFN-gamma production after 3 days by EIA,Other,10096846.0,
124,379089,6,2,,103207024,1794427,Unspecified,,,280.0,IC50,Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay,Confirmatory,10096863.0,
125,379093,3,4,,103207024,1794427,Active,,,,,Growth inhibition of BALB/c mouse cloned 3T3/A31 cells at 100 ug/mL after 72 hrs by nigrosin assay,Other,10096863.0,
126,379094,3,4,,103207024,1794427,Unspecified,,,,,Stimulation of BALB/c mouse cloned 3T3/A31 cells growth at 0.01 to 0.1 ug/mL,Other,10096863.0,
127,391607,6,2,,103207024,1794427,Unspecified,,,2822.5,IC50,Inhibition of Bacillus stearothermophilus alpha-glucosidase,Confirmatory,18783210.0,
128,391608,6,2,,103207024,1794427,Unspecified,,,2822.5,IC50,Inhibition of Saccharomyces cerevisiae alpha-glucosidase,Confirmatory,18783210.0,
129,397153,11,1,,103207024,1794427,Unspecified,,,,,Antioxidant activity against Cu2+-induced lipid peroxidation in human plasma LDL preincubated for 1 hr before Cu2+ challenge,Other,11325231.0,
130,397154,8,1,,103207024,1794427,Unspecified,,,,,Antioxidant activity against AAPH-induced lipid peroxidation in human plasma LDL preincubated for 1 hr before AAPH challenge,Other,11325231.0,
131,397586,3,9,,103207024,1794427,Unspecified,2497687.0,7941.0,,,Effect on human plasma LDL-PLA2 activity by LS-3B fluorescence spectrometry,Other,11325231.0,
132,419926,3,7,,103207024,1794427,Unspecified,,,,,Inhibition of LCK SH2 domain at 200 uM,Other,19427202.0,
133,419927,3,7,,103207024,1794427,Unspecified,,,,,Inhibition of SRC SH2 domain at 200 uM,Other,19427202.0,
134,419928,3,7,,103207024,1794427,Unspecified,,,,,Inhibition of STAT1 SH2 domain at 200 uM,Other,19427202.0,
135,420054,3,7,,103207024,1794427,Unspecified,,,,,Inhibition of STAT3 SH2 domain at 200 uM,Other,19427202.0,
136,420055,3,8,,103207024,1794427,Unspecified,,,,,Inhibition of STAT5b SH2 domain at 200 uM,Other,19427202.0,
137,434955,1,2,,56463713,1794427,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
138,434959,1,1,,85788779,1794427,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
139,434962,1,2,,56463713,1794427,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
140,434973,1,3,,56463713,1794427,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
141,434989,1,1,,56463713,1794427,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
142,435003,1,3,,56463713,1794427,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
143,435005,1,1,,56463713,1794427,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
144,435022,2,2,,56463713,1794427,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
145,435030,1,2,,56463713,1794427,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
146,435030,1,2,,56463713,1794427,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
147,447578,3,4,,103207024,1794427,Unspecified,2498443.0,3065.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
148,447578,3,4,,103207024,1794427,Unspecified,3334210.0,8841.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
149,447578,3,4,,103207024,1794427,Unspecified,19865267.0,9734.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
150,447578,3,4,,103207024,1794427,Unspecified,26394832.0,79885.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
151,447578,3,4,,103207024,1794427,Unspecified,27734403.0,83933.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
152,447578,3,4,,103207024,1794427,Unspecified,29839394.0,55869.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
153,447578,3,4,,103207024,1794427,Unspecified,30913097.0,51564.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
154,447578,3,4,,103207024,1794427,Unspecified,68068066.0,3066.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
155,447578,3,4,,103207024,1794427,Unspecified,205371758.0,10013.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
156,447578,3,4,,103207024,1794427,Unspecified,259016348.0,9759.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
157,447578,3,4,,103207024,1794427,Unspecified,296434519.0,10014.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
158,447579,8,1,,103207024,1794427,Unspecified,2498443.0,3065.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
159,447579,8,1,,103207024,1794427,Unspecified,3334210.0,8841.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
160,447579,8,1,,103207024,1794427,Unspecified,19865267.0,9734.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
161,447579,8,1,,103207024,1794427,Unspecified,26394832.0,79885.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
162,447579,8,1,,103207024,1794427,Unspecified,27734403.0,83933.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
163,447579,8,1,,103207024,1794427,Unspecified,29839394.0,55869.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
164,447579,8,1,,103207024,1794427,Unspecified,30913097.0,51564.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
165,447579,8,1,,103207024,1794427,Unspecified,68068066.0,3066.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
166,447579,8,1,,103207024,1794427,Unspecified,205371758.0,10013.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
167,447579,8,1,,103207024,1794427,Unspecified,259016348.0,9759.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
168,447579,8,1,,103207024,1794427,Unspecified,296434519.0,10014.0,375.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
169,449328,3,4,,103207024,1794427,Active,,,,,Antioxidant activity assessed as DPPH radical scavenging activity by UV-visible spectrophotometry,Other,19674895.0,
170,449728,1,2,,56463713,1794427,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
171,449762,1,2,,56463713,1794427,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
172,449763,1,3,,56463713,1794427,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
173,463079,1,2,,56463713,1794427,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
174,463082,1,1,,56463713,1794427,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
175,463104,1,2,,56463713,1794427,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
176,463141,1,2,,56463713,1794427,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
177,463190,1,2,,56463713,1794427,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
178,463195,1,2,,56463713,1794427,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
179,463210,1,2,,56463713,1794427,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
180,463212,1,1,,56463713,1794427,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
181,463254,1,1,,56463713,1794427,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
182,465832,3,3,,103207024,1794427,Inactive,,,,,Hepatoprotective activity in rat WB-F344 cells assessed as inhibition of D-galactosamine-induced cytotoxicity at 10 uM after 1 hrs by MTT assay relative to control treated before D-galactosamine challenge,Other,20092289.0,
183,485270,1,1,,56463713,1794427,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
184,485272,1,1,,56463713,1794427,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
185,485273,2,1,,56463713,1794427,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
186,485275,1,3,,56463713,1794427,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
187,485294,1,1,,56463713,1794427,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
188,485297,1,1,,56463713,1794427,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
189,485298,1,1,,56463713,1794427,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
190,485313,1,2,,56463713,1794427,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
191,485317,1,2,,56463713,1794427,Active,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
192,485341,1,1,,56463713,1794427,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
193,485344,1,1,,56463713,1794427,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
194,485346,1,1,,56463713,1794427,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
195,485346,1,1,,56463713,1794427,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
196,485347,1,2,,56463713,1794427,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
197,485349,1,1,,56463713,1794427,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
198,485350,1,2,,92124901,1794427,Active,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
199,485350,1,2,,92125380,1794427,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
200,485358,1,1,,56463713,1794427,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
201,485360,1,1,,56463713,1794427,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
202,485364,1,1,,56463713,1794427,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
203,485367,1,2,,56463713,1794427,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
204,488837,1,1,,56463713,1794427,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
205,488839,1,1,,56463713,1794427,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
206,488839,1,1,,56463713,1794427,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
207,488847,1,3,,56463713,1794427,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
208,488862,1,1,,56463713,1794427,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
209,488890,1,2,,56463713,1794427,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
210,488895,1,2,,56463713,1794427,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
211,488896,1,1,,56463713,1794427,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
212,488899,1,1,,56463713,1794427,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
213,488965,1,2,,56463713,1794427,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
214,488966,1,1,,56463713,1794427,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
215,488975,1,2,,56463713,1794427,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
216,488977,1,2,,56463713,1794427,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
217,489030,2,1,,56463713,1794427,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
218,489031,2,1,,56463713,1794427,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
219,492140,3,3,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay,Other,20565070.0,
220,492947,1,1,,56463713,1794427,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
221,492953,1,1,,56463713,1794427,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
222,492956,1,1,,56463713,1794427,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
223,492967,1,2,,92125380,1794427,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
224,492972,1,1,,56463713,1794427,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
225,493005,1,1,,56463713,1794427,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
226,493008,1,1,,56463713,1794427,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
227,493008,1,1,,56463713,1794427,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
228,493008,1,1,,56463713,1794427,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
229,493008,1,1,,56463713,1794427,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
230,493011,1,1,,56463713,1794427,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
231,493012,1,1,,56463713,1794427,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
232,493014,1,1,,56463713,1794427,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
233,493033,1,2,,92124901,1794427,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
234,493033,1,2,,92125380,1794427,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
235,493036,1,2,,56463713,1794427,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
236,493056,1,1,,56463713,1794427,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
237,493084,1,1,,56463713,1794427,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
238,493087,1,1,,56463713,1794427,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
239,493091,1,1,,56463713,1794427,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
240,493098,1,1,,56463713,1794427,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
241,493131,1,1,,56463713,1794427,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
242,493140,1,1,,103913693,1794427,Inactive,,,,,Screening small molecules to find regulators of human embryonic stem cell survival.,Screening,,
243,493160,1,1,,56463713,1794427,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
244,493187,1,2,,56463713,1794427,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
245,493244,1,1,,56463713,1794427,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
246,493244,1,1,,56463713,1794427,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
247,493244,1,1,,56463713,1794427,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
248,493244,1,1,,56463713,1794427,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
249,504326,1,2,,56463713,1794427,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
250,504326,1,2,,56463713,1794427,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
251,504327,1,1,,56463713,1794427,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
252,504329,1,1,,56463713,1794427,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
253,504332,1,1,,56463713,1794427,Active,168985070.0,,12.5893,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
254,504333,1,1,,56463713,1794427,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
255,504339,1,1,,56463713,1794427,Active,162330054.0,,17.7828,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
256,504357,1,1,,56463713,1794427,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
257,504357,1,1,,56463713,1794427,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
258,504406,1,1,,56463713,1794427,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
259,504411,1,1,,56463713,1794427,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
260,504414,1,1,,56463713,1794427,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
261,504414,1,1,,56463713,1794427,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
262,504423,1,1,,56463713,1794427,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
263,504441,1,1,,56463713,1794427,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
264,504444,1,1,,56463713,1794427,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
265,504451,1,1,,56463713,1794427,Inactive,148539876.0,156.0,,,"Confirmation of RNA aptamer-based HTS for inhibitors of GRK2, Cherry Pick 1",Screening,,
266,504454,1,3,,56463713,1794427,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
267,504462,1,1,,56463713,1794427,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
268,504466,1,1,,56463713,1794427,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
269,504467,1,1,,56463713,1794427,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
270,504490,1,2,,56463713,1794427,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
271,504523,1,1,,56463713,1794427,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
272,504523,1,1,,56463713,1794427,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
273,504558,1,1,,56463713,1794427,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
274,504577,2,2,,56463713,1794427,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
275,504580,1,1,,56463713,1794427,Inactive,,,,,"Single point concentration counter screen of potential quenchers of fluorescent RNA aptamer utilized in HTS of GRK2 binding screen, Cherry Pick 1",Other,,
276,504582,2,1,,56463713,1794427,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
277,504621,1,1,,56463713,1794427,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
278,504634,1,1,,56463713,1794427,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
279,504648,1,1,,56463713,1794427,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
280,504651,1,1,,56463713,1794427,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
281,504652,1,1,,56463713,1794427,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
282,504660,1,1,,56463713,1794427,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
283,504690,1,3,,56463713,1794427,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
284,504692,2,2,,56463713,1794427,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
285,504700,1,1,,56463713,1794427,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
286,504700,1,1,,56463713,1794427,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
287,504706,1,1,,56463713,1794427,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
288,504707,1,1,,56463713,1794427,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
289,504707,1,1,,56463713,1794427,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
290,504720,1,1,,56463713,1794427,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
291,504734,1,1,,56463713,1794427,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
292,504766,2,1,,56463713,1794427,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
293,504770,1,2,,92124901,1794427,Inactive,9657380.0,2612528.0,,,A screen for compounds that inhibit replication of Vibrio cholerae chromosome II,Other,,
294,504775,1,1,,56463713,1794427,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
295,504803,1,1,,56463713,1794427,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
296,504810,1,2,,56463713,1794427,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
297,504812,1,2,,56463713,1794427,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
298,504832,1,1,,56463713,1794427,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
299,504834,1,1,,56463713,1794427,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
300,504842,1,1,,56463713,1794427,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
301,504845,1,1,,56463713,1794427,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
302,504847,1,1,,56463713,1794427,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
303,504884,1,2,,56463713,1794427,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
304,504891,1,1,,56463713,1794427,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
305,504894,1,1,,56463713,1794427,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
306,504937,1,2,,56463713,1794427,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
307,515789,7,5,,103207024,1794427,Unspecified,74581833.0,,90.0,IC50,"Inhibition of Candida albicans 1,3 beta-D-glucan synthase",Confirmatory,20813534.0,
308,515790,6,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Candida albicans by NCCLS method,Other,20813534.0,
309,540253,1,1,,56463713,1794427,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
310,540253,1,1,,56463713,1794427,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
311,540253,1,1,,56463713,1794427,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
312,540263,1,1,,56463713,1794427,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
313,540263,1,1,,56463713,1794427,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
314,540267,1,1,,56463713,1794427,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
315,540275,1,1,,56463713,1794427,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
316,540277,1,1,,56463713,1794427,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
317,540295,1,1,,56463713,1794427,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
318,540299,1,2,,92124901,1794427,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
319,540299,1,2,,92125380,1794427,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
320,540303,1,1,,56463713,1794427,Inactive,6679377.0,18792.0,1.122,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
321,540303,1,1,,56463713,1794427,Inactive,7242179.0,18793.0,1.122,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
322,540303,1,1,,56463713,1794427,Inactive,257471003.0,18815.0,1.122,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
323,540308,1,1,,56463713,1794427,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
324,540317,1,1,,56463713,1794427,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
325,540336,1,1,,56463713,1794427,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
326,540336,1,1,,56463713,1794427,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
327,540364,1,2,,56463713,1794427,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
328,579999,2,3,,103207024,1794427,Unspecified,,,,,Antiobesity activity against high-fat diet fed ICR mouse assessed as change in initial body weight after 4 weeks (high fat diet fed group = 25.9 +/- 0.38 g),Other,21324693.0,
329,580000,2,3,,103207024,1794427,Unspecified,,,,,Antiobesity activity against high-fat diet fed ICR mouse assessed as change in final body weight after 4 weeks (high fat diet fed group = 35.5 +/- 0.68 g),Other,21324693.0,
330,580001,2,3,,103207024,1794427,Unspecified,,,,,Antiobesity activity against high-fat diet fed ICR mouse assessed as change in body weight after 4 weeks (high fat diet fed group = 9.50 +/- 0.68 g),Other,21324693.0,
331,580002,2,3,,103207024,1794427,Unspecified,,,,,Antiobesity activity against high-fat diet fed ICR mouse assessed as change in food intake per day after 4 weeks (high fat diet fed group = 5.51 +/- 0.20 g/day),Other,21324693.0,
332,580003,2,3,,103207024,1794427,Inactive,,,,,Antiobesity activity against high-fat diet fed ICR mouse assessed as decrease in weight adipose tissue weight after 4 weeks relative to high-fat diet fed group,Other,21324693.0,
333,580004,2,3,,103207024,1794427,Active,,,,,Antiobesity activity against high-fat diet fed ICR mouse assessed as decrease in plasma triglyceride level after 4 weeks relative to high-fat diet fed group,Other,21324693.0,
334,580005,2,3,,103207024,1794427,Active,,,,,Antiobesity activity against high-fat diet fed ICR mouse assessed as decrease in plasma free fatty acid level after 4 weeks relative to high-fat diet fed group,Other,21324693.0,
335,580006,2,3,,103207024,1794427,Active,,,,,Antiobesity activity against high-fat diet fed ICR mouse assessed as increase in basal metabolic rate at 0.1 % after 4 weeks,Other,21324693.0,
336,588334,1,1,,56463713,1794427,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
337,588335,1,1,,56463713,1794427,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
338,588342,1,1,,56463713,1794427,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
339,588352,1,2,,56463713,1794427,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
340,588354,1,1,,56463713,1794427,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
341,588358,1,2,,56463713,1794427,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
342,588391,1,1,,56463713,1794427,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
343,588405,1,1,,56463713,1794427,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
344,588413,1,2,,56463713,1794427,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
345,588436,1,1,,56463713,1794427,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
346,588453,1,1,,56463713,1794427,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
347,588456,1,1,,56463713,1794427,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
348,588458,1,1,,56463713,1794427,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
349,588473,1,1,,56463713,1794427,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
350,588473,1,1,,56463713,1794427,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
351,588475,1,2,,56463713,1794427,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
352,588475,1,2,,56463713,1794427,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
353,588478,1,2,,124801155,1794427,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
354,588489,1,1,,56463713,1794427,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
355,588492,1,1,,56463713,1794427,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
356,588493,1,2,,56463713,1794427,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
357,588497,1,2,,56463713,1794427,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
358,588497,1,2,,56463713,1794427,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
359,588497,1,2,,56463713,1794427,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
360,588499,1,3,,56463713,1794427,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
361,588499,1,3,,56463713,1794427,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
362,588499,1,3,,56463713,1794427,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
363,588501,1,2,,56463713,1794427,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
364,588501,1,2,,56463713,1794427,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
365,588501,1,2,,56463713,1794427,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
366,588511,1,2,,56463713,1794427,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
367,588519,1,2,,92124901,1794427,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
368,588519,1,2,,92125380,1794427,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
369,588549,1,1,,56463713,1794427,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
370,588579,1,1,,56463713,1794427,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
371,588590,1,1,,56463713,1794427,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
372,588591,1,1,,56463713,1794427,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
373,588621,1,1,,56463713,1794427,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
374,588627,1,1,,56463713,1794427,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
375,588664,1,2,,56463713,1794427,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
376,588664,1,2,,56463713,1794427,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
377,588674,1,2,,56463713,1794427,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
378,588675,1,1,,56463713,1794427,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
379,588676,1,1,,56463713,1794427,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
380,588689,1,1,,56463713,1794427,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
381,588692,2,1,,56463713,1794427,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
382,588726,1,2,,56463713,1794427,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
383,588727,1,1,,56463713,1794427,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
384,588795,1,1,,56463713,1794427,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
385,588814,1,3,,56463713,1794427,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
386,588819,1,4,,56463713,1794427,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
387,588850,1,1,,56463713,1794427,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
388,588852,1,3,,56463713,1794427,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
389,588855,1,1,,56463713,1794427,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
390,588856,1,1,,56463713,1794427,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
391,592088,3,2,,103207024,1794427,Active,,,0.2,IC50,Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhage incubated with compound for 10 mins measured after 24 hrs,Confirmatory,21388814.0,
392,592361,3,3,,103207024,1794427,Active,,,20.0,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins in dark by spectrophotometry,Confirmatory,21341711.0,
393,602123,1,1,,56463713,1794427,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
394,602141,1,1,,56463713,1794427,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
395,602162,1,1,,56463713,1794427,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
396,602163,1,1,,56463713,1794427,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
397,602179,1,2,,56463713,1794427,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
398,602229,1,1,,56463713,1794427,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
399,602233,1,1,,56463713,1794427,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
400,602244,1,2,,56463713,1794427,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
401,602247,1,2,,56463713,1794427,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
402,602248,1,2,,56463713,1794427,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
403,602250,1,2,,56463713,1794427,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
404,602252,1,1,,56463713,1794427,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
405,602252,1,1,,56463713,1794427,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
406,602261,1,1,,56463713,1794427,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
407,602274,1,2,,56463713,1794427,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
408,602281,1,1,,56463713,1794427,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
409,602281,1,1,,56463713,1794427,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
410,602310,1,2,,56463713,1794427,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
411,602313,1,1,,56463713,1794427,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
412,602314,1,2,,92124901,1794427,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
413,602314,1,2,,92125380,1794427,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
414,602329,1,1,,56463713,1794427,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
415,602332,1,1,,56463713,1794427,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
416,602340,1,2,,56463713,1794427,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
417,602342,2,1,,56463713,1794427,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
418,602346,1,1,,56463713,1794427,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
419,602363,1,1,,56463713,1794427,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
420,602393,1,1,,56463713,1794427,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
421,602396,1,2,,56463713,1794427,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
422,602399,1,2,,56463713,1794427,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
423,602405,1,1,,56463713,1794427,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
424,602410,1,1,,56463713,1794427,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
425,602429,1,1,,56463713,1794427,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
426,602438,1,1,,56463713,1794427,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
427,602440,1,1,,56463713,1794427,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
428,602449,1,2,,56463713,1794427,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
429,602481,1,1,,56463713,1794427,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
430,623870,1,1,,56463713,1794427,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
431,623870,1,1,,56463713,1794427,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
432,623877,1,1,,56463713,1794427,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
433,623901,1,1,,56463713,1794427,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
434,624037,1,3,,56463713,1794427,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
435,624038,1,3,,56463713,1794427,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
436,624040,1,3,,56463713,1794427,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
437,624101,1,2,,85788779,1794427,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
438,624125,1,4,,56463713,1794427,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
439,624126,1,3,,56463713,1794427,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
440,624127,1,2,,56463713,1794427,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
441,624137,1,1,,85788779,1794427,Inactive,881546.0,3400.0,,,SMM ID4 Measured in Biochemical System Using Small Molecule MicroArray - 2128-01_Other_SinglePoint_HTS_Activity,Screening,,
442,624151,1,1,,85788779,1794427,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Re-Activators of the P53 Mutant Pathway Measured in Cell-Based System Using Plate Reader - 2071-01_Activator_SinglePoint_HTS_Activity,Screening,,
443,624156,1,1,,85788779,1794427,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
444,624168,1,1,,56463713,1794427,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
445,624169,1,1,,56463713,1794427,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
446,624170,1,1,,56463713,1794427,Inconclusive,71051501.0,2744.0,35.4813,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
447,624171,1,1,,56463713,1794427,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
448,624172,1,1,,56463713,1794427,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
449,624173,1,3,,56463713,1794427,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
450,624178,1,1,,56463713,1794427,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
451,624202,1,1,,56463713,1794427,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
452,624204,1,2,,56463713,1794427,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
453,624246,1,1,,56463713,1794427,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
454,624256,1,2,,56463713,1794427,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
455,624260,1,1,,85788779,1794427,Inactive,109633019.0,7468.0,,,NSD2 Inhibitors Measured in Biochemical System Using Plate Reader - 2115-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
456,624263,1,1,,56463713,1794427,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
457,624263,1,1,,56463713,1794427,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
458,624267,1,2,,56463713,1794427,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
459,624267,1,2,,56463713,1794427,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
460,624268,1,3,,56463713,1794427,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
461,624288,1,1,,56463713,1794427,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
462,624296,1,1,,56463713,1794427,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
463,624297,1,1,,56463713,1794427,Inactive,7705682.0,51053.0,3.2643,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
464,624304,1,2,,56463713,1794427,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
465,624330,1,2,,56463713,1794427,Inconclusive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
466,624349,1,2,,92125380,1794427,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
467,624349,1,2,,121363051,1794427,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
468,624352,1,1,,56463713,1794427,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
469,624354,1,1,,56463713,1794427,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
470,624377,1,1,,56463713,1794427,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
471,624414,1,1,,56463713,1794427,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
472,624415,1,2,,56463713,1794427,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
473,624416,1,1,,56463713,1794427,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
474,624417,1,1,,56463713,1794427,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
475,624418,1,1,,56463713,1794427,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
476,624463,1,1,,56463713,1794427,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
477,624464,1,1,,56463713,1794427,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
478,624465,1,1,,56463713,1794427,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
479,624466,1,3,,56463713,1794427,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
480,624467,1,1,,56463713,1794427,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
481,624483,1,1,,56463713,1794427,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
482,624609,1,9,,103207024,1794427,Unspecified,29840832.0,54578.0,,,Specific activity of expressed human recombinant UGT1A6,Other,10836148.0,
483,624612,1,9,,103207024,1794427,Unspecified,29839451.0,54600.0,,,Specific activity of expressed human recombinant UGT1A9,Other,10836148.0,
484,639825,5,5,,103207024,1794427,Active,113596.0,231.0,1.8,IC50,Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry,Confirmatory,22261024.0,
485,641085,7,2,,103207024,1794427,Active,113596.0,231.0,0.3,IC50,Inhibition of human recombinant N-terminus His6-tagged AKR1B1 expressed in Escherichia coli BL21 DE3 assessed as pyridine-3-aldehyde reduction by spectrometric analysis,Confirmatory,22236472.0,
486,641086,7,2,,103207024,1794427,Active,322510010.0,57016.0,7.9,IC50,Inhibition of human recombinant N-terminus His6-tagged AKR1B10 expressed in Escherichia coli BL21 DE3 assessed as pyridine-3-aldehyde reduction by spectrometric analysis,Confirmatory,22236472.0,
487,651548,1,1,,85788779,1794427,Inactive,21361095.0,2146.0,,,EZH2/PRC2 methyltransferase inhibitors Measured in Biochemical System Using Plate Reader - 2125-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
488,651560,1,1,,56463713,1794427,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
489,651572,1,2,,56463713,1794427,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
490,651582,1,1,,56463713,1794427,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
491,651602,1,1,,56463713,1794427,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
492,651602,1,1,,56463713,1794427,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
493,651602,1,1,,56463713,1794427,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
494,651610,2,1,,56463713,1794427,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
495,651635,1,3,,56463713,1794427,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
496,651636,1,1,,56463713,1794427,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
497,651640,1,1,,56463713,1794427,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
498,651644,1,1,,56463713,1794427,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
499,651647,1,1,,56463713,1794427,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
500,651654,1,1,,56463713,1794427,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
501,651658,1,1,,56463713,1794427,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
502,651661,2,1,,56463713,1794427,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
503,651687,1,1,,56463713,1794427,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
504,651699,1,1,,56463713,1794427,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
505,651699,1,1,,56463713,1794427,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
506,651702,1,2,,56463713,1794427,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
507,651704,2,1,,56463713,1794427,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
508,651710,1,1,,56463713,1794427,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
509,651711,2,1,,56463713,1794427,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
510,651718,1,2,,56463713,1794427,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
511,651719,1,2,,56463713,1794427,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
512,651723,1,1,,56463713,1794427,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
513,651724,1,1,,56463713,1794427,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
514,651725,1,1,,56463713,1794427,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
515,651768,1,2,,56463713,1794427,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
516,651800,1,1,,56463713,1794427,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
517,651819,1,1,,56463713,1794427,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
518,651820,1,1,,56463713,1794427,Inconclusive,,,5.0119,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
519,651821,2,4,,56463713,1794427,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
520,651957,1,1,,56463713,1794427,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
521,651958,1,1,,56463713,1794427,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
522,651965,1,1,,56463713,1794427,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
523,651999,1,1,,56463713,1794427,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
524,652010,1,1,,56463713,1794427,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
525,652017,1,1,,56463713,1794427,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
526,652025,1,1,,56463713,1794427,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
527,652039,1,1,,56463713,1794427,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
528,652048,1,2,,56463713,1794427,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
529,652051,1,1,,56463713,1794427,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
530,652054,1,1,,56463713,1794427,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
531,652067,1,4,,56463713,1794427,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
532,652104,1,1,,56463713,1794427,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
533,652105,1,1,,56463713,1794427,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
534,652106,1,1,,56463713,1794427,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
535,652115,1,1,,56463713,1794427,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
536,652126,1,3,,56463713,1794427,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
537,652154,1,1,,56463713,1794427,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
538,652162,2,1,,56463713,1794427,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
539,652163,1,1,,56463713,1794427,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
540,652197,1,1,,56463713,1794427,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
541,652257,1,1,,56463713,1794427,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
542,654332,2,2,,103207024,1794427,Unspecified,,,50.0,IC50,Inhibition of advanced glycation end-products formation after 14 days by spectrofluorimetry,Confirmatory,22264115.0,
543,654333,5,5,,103207024,1794427,Active,1168407.0,24192.0,0.95,IC50,Inhibition of Sprague-Dawley rat lens aldose reductase,Confirmatory,22264115.0,
544,686940,1,1,,56463713,1794427,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
545,686964,1,1,,56463713,1794427,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
546,686970,1,2,,56463713,1794427,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
547,686971,1,2,,56463713,1794427,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
548,686977,2,1,,49698484,1794427,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
549,686978,1,1,,56463713,1794427,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
550,686979,1,1,,56463713,1794427,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
551,686992,2,1,,56463713,1794427,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
552,687014,1,1,,56463713,1794427,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
553,687016,1,1,,56463713,1794427,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
554,688479,3,1,,103207024,1794427,Unspecified,112927.0,351.0,,IC50,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Confirmatory,22921742.0,
555,697852,1,7,,103207024,1794427,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
556,697853,1,7,,103207024,1794427,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
557,718317,1,4,,103207024,1794427,Active,,,,,Antioxidant activity assessed as DPPH radical scavenging activity,Other,23237411.0,
558,718318,1,3,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at 40 mins by TEAC assay,Other,23237411.0,
559,718319,1,3,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at 30 mins by TEAC assay,Other,23237411.0,
560,718320,1,3,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at 35 mins by TEAC assay,Other,23237411.0,
561,718321,1,3,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at 25 mins by TEAC assay,Other,23237411.0,
562,718322,1,3,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at 20 mins by TEAC assay,Other,23237411.0,
563,718323,1,3,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at 15 mins by TEAC assay,Other,23237411.0,
564,718324,1,3,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at 5 mins by TEAC assay,Other,23237411.0,
565,718454,1,3,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at 10 mins by TEAC assay,Other,23237411.0,
566,718455,1,3,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at 0 min by TEAC assay,Other,23237411.0,
567,720504,1,1,,56463713,1794427,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
568,720508,1,1,,56463713,1794427,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
569,720509,1,1,,56463713,1794427,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
570,720511,1,1,,56463713,1794427,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
571,720517,1,1,,56463713,1794427,Inactive,,,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: FP59 Counterscreen for Cherry-picked Compounds,Confirmatory,,
572,720518,1,1,,56463713,1794427,Inactive,,,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Wild-type Protective Antigen (WT-PrAg) Counterscreen for Cherry-picked Compounds,Confirmatory,,
573,720519,1,2,,56463713,1794427,Inactive,4505863.0,5328.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Confirmatory Assay for Cherry-picked Compounds,Confirmatory,,
574,720542,1,2,,56463713,1794427,Inactive,23496270.0,810891.0,39.8107,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
575,720543,1,1,,56463713,1794427,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
576,720551,1,2,,56463713,1794427,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
577,720553,1,2,,56463713,1794427,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
578,720579,2,1,,56463713,1794427,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
579,720580,1,1,,56463713,1794427,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
580,720582,1,1,,56463713,1794427,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
581,720596,1,1,,56463713,1794427,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
582,720647,1,2,,56463713,1794427,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
583,720648,1,1,,56463713,1794427,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
584,720700,1,4,,56463713,1794427,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
585,720702,1,1,,56463713,1794427,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
586,720704,1,4,,56463713,1794427,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
587,720707,1,2,,56463713,1794427,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
588,720708,1,2,,56463713,1794427,Inconclusive,32171491.0,11069.0,39.8107,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
589,720709,1,2,,56463713,1794427,Inconclusive,317373593.0,10411.0,31.6228,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
590,720711,1,2,,56463713,1794427,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
591,720717,1,3,,92124901,1794427,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
592,720717,1,3,,92125380,1794427,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
593,735121,1,2,,103207024,1794427,Unspecified,,,,,Gastroprotective activity in rat assessed as protection against ethanol-induced gastric injury,Other,23398496.0,
594,736009,3,2,,103207024,1794427,Active,,,45.5,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader,Confirmatory,23356964.0,
595,743126,1,1,,56463713,1794427,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
596,743238,1,1,,56463713,1794427,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
597,743247,1,2,,56463713,1794427,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
598,743255,1,1,,56463713,1794427,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
599,743266,1,2,,56463713,1794427,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
600,743269,1,1,,56463713,1794427,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
601,743269,1,1,,56463713,1794427,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
602,743279,1,2,,56463713,1794427,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
603,743397,1,1,,56463713,1794427,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
604,743398,1,1,,56463713,1794427,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
605,768928,1,5,,103207024,1794427,Inactive,135807.0,2147.0,,,Inhibition of human thrombin amidolytic activity using D-Phe-Pip-Arg-pNA as substrate at 0.1 to 1000 uM preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by spectrophotometric analysis,Other,24610996.0,
606,780477,1,1,,103207024,1794427,Unspecified,,,,,Inhibition of biofilm formation of Pseudomonas aeruginosa PaM02 at 128 ug/ml after 24 hrs by crystal violet staining-based ELISA reader analysis,Other,24094434.0,
607,780479,1,1,,103207024,1794427,Inactive,,,,,Antimicrobial activity against Pseudomonas aeruginosa PaM02 at > 128 ug/ml by microtitre plate reader analysis,Other,24094434.0,
608,977599,1,1,,103207024,1794427,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
609,977602,1,2,,103207024,1794427,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
610,1053197,1,1,,56463713,1794427,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
611,1056513,1,1,,103207024,1794427,Inactive,,,,,Antiviral activity against HIV1 infected in human 293T cells expressing VSV-G assessed as inhibition of viral p24 production at 10 uM after 48 hrs by ELISA,Other,24279769.0,
612,1056514,1,1,,103207024,1794427,Inactive,,,,,Cytotoxicity against human HCT8 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
613,1056515,1,2,,103207024,1794427,Inactive,,,,,Cytotoxicity against human Ketr3 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
614,1056516,1,1,,103207024,1794427,Inactive,,,,,Cytotoxicity against human Bel7402 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
615,1056517,1,2,,103207024,1794427,Inactive,,,,,Cytotoxicity against human MCF7 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
616,1056518,1,1,,103207024,1794427,Inactive,,,,,Cytotoxicity against human BGC823 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
617,1056519,1,2,,103207024,1794427,Inactive,,,,,Cytotoxicity against human A549 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
618,1056520,1,1,,103207024,1794427,Unspecified,,,,,Antiinflammatory activity in rat polymorphonuclear leukocytes assessed as inhibition of PAF-induced release of glucuronidase at 10 uM,Other,24279769.0,
619,1083149,1,1,,103207024,1794427,Unspecified,,,,,Nematotoxic activity against freshly hatched Meloidogyne incognita J2 (root-knot nematode) isolated from tomato roots assessed as induction of nematode paralysis measured 24 hr after immersion in compound test solutions,Other,23136941.0,
620,1083154,1,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Diplodia seriata BoF98-1 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
621,1083155,1,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Diplodia seriata BoF99-1 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
622,1083156,1,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Diplodia seriata LAT28 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
623,1083157,1,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Lasiodiplodia theobromae CBS116460 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
624,1083158,1,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Diplodia seriata PLU03 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
625,1083159,1,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Diplodia mutila BRA08 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
626,1083160,1,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Neofusicoccum luteum CBS110299 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
627,1083161,1,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Neofusicoccum parvum PER20 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
628,1083162,1,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Neofusicoccum parvum Bp0014 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
629,1083163,1,1,,103207024,1794427,Unspecified,,,,,Antifungal activity against Botryosphaeria dothidea OGE14 assessed as growth inhibition measured after 1 to 10 days relative to control,Other,23145924.0,
630,1083171,1,1,,103207024,1794427,Inactive,,,,,Antifungal activity against Togninia minima SO21 assessed as susceptibility at 500 uM measured after 1 to 10 days,Other,23145924.0,
631,1100608,1,1,,103207024,1794427,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 5 umol/disk by paper disk method,Other,84.0,
632,1100609,1,1,,103207024,1794427,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 0.5 umol/disk by paper disk method,Other,84.0,
633,1119807,3,2,,103207024,1794427,Unspecified,3913718.0,2542.0,226.0,IC50,Inhibition of G6PT1 (unknown origin),Confirmatory,,
634,1119808,2,2,,103207024,1794427,Unspecified,3913718.0,2542.0,260.0,Ki,Competitive inhibition of G6PT1 (unknown origin),Confirmatory,,
635,1151279,1,1,,103207024,1794427,Inactive,,,,,Inhibition of BacLight Green labeled Escherichia coli adherence to human UEC after 1 hr by flow cytometry analysis,Other,24749980.0,
636,1151282,1,1,,103207024,1794427,Unspecified,,,,,Bactericidal activity against BacLight Green labeled Escherichia coli up to 30 ug/ml,Other,24749980.0,
637,1159524,1,1,,56463713,1794427,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
638,1159550,3,1,,252402295,1794427,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
639,1159580,2,1,,268735623,1794427,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
640,1159606,1,1,,56463713,1794427,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
641,1159607,2,1,,312596561,1794427,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
642,1169291,1,2,,103207024,1794427,Inactive,136464.0,7276.0,,EC50,Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation by fluorescence assay,Confirmatory,25314129.0,
643,1172639,1,1,,103207024,1794427,Unspecified,,,,,Inhibition of cell proliferation of human U251 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay,Other,25442304.0,
644,1172640,1,1,,103207024,1794427,Unspecified,,,,,Inhibition of cell proliferation of rat C6 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay,Other,25442304.0,
645,1176142,1,1,,103207024,1794427,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells at 50 uM by MTT assay,Other,25497988.0,
646,1176144,1,1,,103207024,1794427,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated nitric oxide production at 0.4 to 10 uM after 24 hrs by Griess assay,Other,25497988.0,
647,1176146,1,1,,103207024,1794427,Unspecified,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha production at 10 uM by ELISA,Other,25497988.0,
648,1176147,1,1,,103207024,1794427,Unspecified,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha production at 2 uM by ELISA,Other,25497988.0,
649,1179732,1,1,,103207024,1794427,Unspecified,,,,,Antioxidant activity assessed as superoxide anion radical scavenging activity at 10 uM by PMS-NADH-NBT system based spectrophotometry,Other,24924425.0,
650,1193988,1,1,,103207024,1794427,Unspecified,,,50.0,IC50,Inhibition of LPS-induced IL-12 p40 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA,Confirmatory,25769817.0,
651,1193989,1,1,,103207024,1794427,Unspecified,,,50.0,IC50,Inhibition of LPS-induced IL-6 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA,Confirmatory,25769817.0,
652,1193990,1,1,,103207024,1794427,Unspecified,,,50.0,IC50,Inhibition of LPS-induced TNF-alpha production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA,Confirmatory,25769817.0,
653,1223489,1,1,,103207024,1794427,Unspecified,,,,,"1-Octanol-water distribution coefficient, log D of the compound at pH 7.4 by shake flask method",Other,22096083.0,
654,1223493,1,1,,103207024,1794427,Unspecified,,,,,Apparent permeability from apical to basolateral side in human Caco2 cells at 500 uM at pH 7.4 after 1 hr by HPLC-DAD analysis,Other,22096083.0,
655,1223494,1,1,,103207024,1794427,Unspecified,,,,,Apparent permeability from basolateral to apical side in human Caco2 cells at 500 uM at pH 7.4 after 1 hr by HPLC-DAD analysis,Other,22096083.0,
656,1223495,1,1,,103207024,1794427,Unspecified,,,,,Efflux ratio of apparent permeability from basolateral to apical side over apical to basolateral side in human Caco2 cells at 500 uM after 1 hr by HPLC-DAD analysis,Other,22096083.0,
657,1223496,1,1,,103207024,1794427,Unspecified,,,,,Apparent permeability across human Caco2 cells with high TEER resistance at 500 uM after 1 hr by HPLC-DAD analysis,Other,22096083.0,
658,1223497,1,1,,103207024,1794427,Unspecified,,,,,Apparent permeability across human Caco2 cells with low TEER resistance at 500 uM after 1 hr by HPLC-DAD analysis,Other,22096083.0,
659,1224865,1,2,,56463713,1794427,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
660,1256312,1,1,,103207024,1794427,Active,,,,,Increase in glucose-stimulated insulin secretion in rat INS-1E cells at 1 uM after 60 mins in presence of 16.7 mM glucose,Other,26465380.0,
661,1256761,1,1,,103207024,1794427,Inactive,,,,,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate up to 50 nM by spectrophotometric analysis,Other,26491981.0,
662,1256762,1,1,,103207024,1794427,Unspecified,,,,,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate at 10 uM by spectrophotometric analysis relative to control,Other,26491981.0,
663,1256763,1,1,,103207024,1794427,Unspecified,,,291.0,IC50,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate by spectrophotometric analysis,Confirmatory,26491981.0,
664,1259310,1,1,,333473208,1794427,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
665,1259313,1,1,,56463713,1794427,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
666,1259318,1,1,,56463713,1794427,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
667,1259389,1,1,,124636324,1794427,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
668,1259407,1,1,,363899350,1794427,Inactive,,,,,CCRIS mutagenicity studies,Other,,
669,1259409,1,1,,363899350,1794427,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
670,1259415,1,1,,56463713,1794427,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
671,1259421,1,1,,340082152,1794427,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
672,1259423,1,2,,354916202,1794427,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
673,1259423,1,2,,354959654,1794427,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
